Plasma kinetics of a cholesterol-rich microemulsion in subjects with heterozygous β-thalassemia
✍ Scribed by Flávio A. Naoum; Sandra F.M. Gualandro; Maria da Conceição M. Latrilha; Raul C. Maranhão
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 97 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Patients with β‐thalassemia trait have been reported to present lower plasma concentrations of low‐density lipoprotein (LDL) and lower frequencies of acute myocardial infarction than normal subjects. In this study, the metabolism of LDL was tested in 12 patients with heterozygous β‐thalassemia trait (HBT) and 13 healthy subjects without the disease by determining the plasma kinetics of an artificially made cholesterol‐rich microemulsion (LDE) that mimics the LDL metabolism and binds to LDL receptors. The emulsion was labeled with ^14^C‐cholesterol ester and injected intravenously into the subjects. Blood samples were drawn at regular intervals over 24 hr to determine the plasma decay curve of the emulsion radioactive label and to estimate its plasma fractional clearance rate (FCR, in hr^−1^). FCR of the ^14^C‐cholesterol ester was greater in HBT compared to controls (0.0631 ± 0.0178 hr^−1^ and 0.0501 ± 0.0094 hr^−1^, respectively; mean ± SD, P = 0.022). No differences were found regarding LDL cholesterol plasma concentration between the two groups, but apolipoprotein B concentration was lower in HBT than in control subjects (80 ± 44 and 96 ± 14, respectively; mean ± SD, P = 0.026). Our results show that LDE FCR is increased in HBT, indicating that LDL clearance is increased in patients with β‐thalassemia trait possibly due to the increased proliferation in the bone marrow of erythroid precursors. Am. J. Hematol. 77:340–345, 2004. © 2004 Wiley‐Liss, Inc.